# US 2013/0252848 A1 · Cellomics system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0252848 A1
- Document ID: US20130252848A1
- Status: Published application
- Kind: A1
- Application number: 13/755,079
- Filed: 2013-01-31
- Published: 2013-09-26
- Earliest claimed: 2004-08-03
- Assignees: Kanagawa Academy of Science and Technology; OnChip Cellomics Consortium
- Inventors: Kazunori Okano; Kenji Yasuda
- Web page: https://patentgrep.com/patent/US20130252848A1

## CPC

- B01L 7/50: {Cryostats}
- A01N 1/162: Temperature processes, e.g. following predefined temperature changes over time
- G01N 33/5061: {Muscle cells}
- G01N 33/566: using specific carrier or receptor proteins as ligand binding reagents {where possible specific carrier or receptor proteins are classified with their target compounds}
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

In labeling a cell, and separating and collecting the cell according to a degree of the labeling using a cell separator, effects on the cell is minimized and the use of the collected cell is facilitated, thereby, when labeling a cell, the cell is labeled in the state where interaction of each cell is retained. In the labeling, a specific labeling material present on a surface of a target cell is taken in the cell via a transporter, and the cell is dispersed one by one to separate the same with a cell separator. Immediately after the separation, the cell is put in a solution not containing the specific labeling substance to remove the specific labeling substance taken in the cell. This series of steps is continuously conducted with a cell separation chip.

## Claims

### Claim 1

A cardiac muscle cell bioassay chip comprising:
a substrate;
four or more microcompartments arranged on the substrate for forming a network of four or more pulsating myocardial cells which adjoin one another, wherein each of the microcompartments is capable of confining a single pulsating myocardial cell;
a groove or a tunnel connecting between the adjoining microcompartments;
an electrode provided in the groove or the tunnel for measuring a change in electrical potential of the cell; and
a means for supplying a culture medium for the pulsating myocardial cell to the microcompartment.

### Claim 2

A cardiac muscle cell bioassay chip comprising:
a substrate;
four or more microcompartments arranged to adjoin one another on the substrate to form a network, wherein each of the microcompartments is capable of confining a single pulsating myocardial cell;
a groove or a tunnel connecting between the adjoining microcompartments of the four or more microcompartments;
an electrode provided in the inside of the microcompartment and the groove or the tunnel for measuring a change in electrical potential of the cell; and
a means for supplying a culture medium for the pulsating myocardial cell to the microcompartment,
wherein the four or more pulsating myocardial cells are confined in each of the microcompartments one by one so that the four or more pulsating myocardial cells adjoin one another and form a network.

### Claim 3

A cardiac muscle cell bioassay chip, comprising:
a substrate;
four or more microcompartments for confining pulsating myocardial cells one by one, which are arranged to adjoin one another to form a network on the substrate;
a groove or a tunnel connecting between the adjoining microcompartments;
an electrode provided in the inside of the microcompartment and the groove or the tunnel for measuring a change in electrical potential of the cell; and
a means for supplying a culture medium for the pulsating myocardial cell to the microcompartment;
wherein the four or more pulsating myocardial cells are confined in the four or more microcompartments respectively to adjoin one another and form a network.

### Claim 4 (depends on 1)

The cardiac muscle cell bioassay chip according to claim 1, wherein the material constructing the microcompartment is agarose.

### Claim 5 (depends on 1)

The cardiac muscle cell bioassay chip according to claim 1, wherein said bioassay chip comprises eight or more said microcompartments for confining eight or more said pulsating myocardial cells respectively.

### Claim 6

A microarray chip for measuring a change in electrical potential or shape of a pulsating myocardial cell in a network of adjoining pulsating myocardial cells, comprising:
a substrate;
four our more microcompartments arranged on the substrate, wherein four or more pulsating myocardial cells are confined respectively in the microcompartments to adjoin one another and form a network;
a groove or a tunnel connecting between the adjoining microcompartments;
an electrode pattern arranged in the inside of the microcompartment and in the groove or the tunnel for providing an electric stimulus to the cell, and for measuring the change in the electrical potential of the cell when the electric stimulus was provided to the cell; and
an optically transparent semipermeable membrane and a culture medium bath provided on and over the microcompartments.

### Claim 7

A bioassay method comprising:
accommodating a pulsating myocardial cell in each of four or more microcompartments formed on a substrate and connected by a groove or a tunnel to one another;
adding a test sample to the four or more microcompartments adjoined one another;
applying an electrical stimulus to the cell using an electrode arranged in the inside of the microcompartment and the groove or the tunnel;
measuring a change in electrical potential or shape of the cell in the network of the four or more of the adjoining pulsating myocardial cells, each of which is accommodated in each of the microcompartments.

### Claim 8 (depends on 7)

The bioassay method according to claim 7, wherein the testing sample is a biological substance such as a peptide and an amino acid or a chemical substance suspected of being an endocrine disruptors or having toxicity.

### Claim 9

A bioassay method comprising:
preparing an aggregated-cell microarray which comprises on a substrate
four or more microcompartments which adjoin one another and confine four or more pulsating myocardial cells respectively in a specific spatial area;
a groove or a tunnel connecting between the adjoining microcompartments;
a plurality of electrode patterns arranged in the groove or the tunnel for measuring an electrical potential of the cell; and
an optically transparent semipermeable membrane and a culture medium bath provided on and over the microcompartments,
accommodating a single pulsating myocardial cell in each of the adjoining four or more microcompartments;
applying an electrical stimulus to the cells using the electrode arranged in the groove or the tunnel; and
measuring a change in the electrical potential or the shape of the pulsating myocardial cell in the network of the four or more pulsating myocardial cells accommodated in the microcompartments.

### Claim 10 (depends on 7)

The bioassay method according to claim 7, wherein eight or more microcompartments are formed on the substrate, and an eight or more pulsating myocardial cells are used.

### Claim 11 (depends on 9)

The bioassay method according to claim 9, wherein eight or more microcompartments are formed on the substrate, and an eight or more pulsating myocardial cells are used.

### Claim 12 (depends on 7)

The bioassay method according to claim 7, wherein the material for constructing the microcompartment is agarose.

### Claim 13 (depends on 9)

The bioassay method according to claim 9, wherein the material for constructing the microcompartment is agarose.
